1999-05-27T00:00:00
The Multiple Sclerosis Society is calling for the National Institute for Clinical Excellence to look at the provision of beta interferon to ensure it is 'available equitably to those patients whose consultants believe they will benefit from it'. In an adjournment debate in the House of Commons, MP John Bercow ...
With a HSJ subscription you’ll unlock:
Already a subscriber? Sign into your account here
Part of HSJ Information Ltd. 5th Floor, Aldgate Tower, 2 Leman Street, London E1 8FA. Registered in England and Wales. Company registration 2530185
Site powered by Webvision Cloud